Study/year | N = | Age | Gender | Grade | Size in cm | Location in relation to fascia | Excision margin | Adjuvant treatment | LR | DM | Survival data |
---|---|---|---|---|---|---|---|---|---|---|---|
Hashimoto et al. 1986a [11] | 24 | Median 55 | M: 8 F: 16 | 1: 6 2: 14 3: 5 | ≤ 5: 8 > 5: 12 NR: 3 | Above: 11 Below: 13 | Marginal: 21 Wide: 2 Amputation: 1 | CT: 5 RT: 2 | 11 | 9 | 5-year survival 61% |
Gustafson et al. 1992 [1] | 48 | Median 65 | M: 26 F: 22 | 1: 2 2: 4 3: 17 4: 25 | ≤ 5: 24 > 5: 24 | Above: 21 Below: 27 | Intralesional: 1 Marginal: 21 Wide: 26 | CT: 8 RT: 11 | 10 | 20 | 5-year survival 64% |
Miyajima et al. 2002b [8] | 267 | Median 58 | M: 125 F: 142 | 1: 110 2: 115 3: 42 | ≤ 5: 43 > 5: 143 NR: 83 | Above: 105 Below: 162 | Resection: 264 Unresectable: 3 | 0 | NR | NR | AJCC 5-year survival Stage I 78% Stage II 49% Stage III 35% Stage IV 0% |
Farshid et al. 2002 [4] | 42 | Mean 60 | M: 21 F: 21 | 1 and 2: 20 3: 18 NR: 4 | ≤ 4: 18 > 4: 20 NR: 4 | Above: 15 Below: 27 | Intralesional: 4 Marginal: 13 Wide: 21 Indeterminate: 4 | CT: 2 RT: 11 | 3 | 17 | Median survival 35 months |
Massi et al. 2004 [7] | 42 | Median 67.5 | M: 20 F: 22 | 1: 1 2: 12 3: 29 | ≤ 5: 9 > 5: 33 | Above: 1 Below: 41 | Intralesional: 5 Marginal: 4 Wide: 33 | CT: 9 RT: 21 | 9 | 16 | 5-year survival 32.6% |
Svarvar et al. 2006c [12] | 225 | Median 70 | M: 104 F: 121 | 1: 6 2: 33 3: 75 4: 108 NR: 3 | ≤ 5: 129 > 5: 91 | Above: 137 Below: 88 | Intralesional: 21 Marginal: 69 Wide: 129 No surgery: 6 | CT: 11 RT: 64 | NR | 76 | 5-year survival 64% |
Tsiatis et al. 2009 [13] | 28 | Mean 59 | M: 14 F: 14 | 1: 3 2: 6 3: 19 | NR | Below: 28 | NR | RT: 20 | NR | NR | Median survival 35 months |
Abraham et al. 2012d [14] | 115 | Mean 58 | M: 48 F: 67 | 1: 10 2: 25 3: 80 | ≤ 5: 31 > 5: 84 | Above: 20 Below: 95 | Intralesional: 17 Marginal: 15 Wide: 57 No surgery: 26 | CT: 45 RT: 45 | 31 | 70 | 5-year survival 57% |
Gladdy et al. 2013e [6] | 353 | Median 57 | M: 196 F: 157 | High: 265 Low: 88 | ≤ 5: 155 > 5: 194 | Above: 96 Below: 257 | Intralesional/marginal: 64 Wide: 289 | NR | 46 | 109 | 5-year survival 75%: extremity 81%: trunk |
Farid et al. 2013f [15] | 46 | Median 55 | M: 23 F: 23 | NR | NR | NR | Intralesional/marginal: 12 Wide: 10 | RT: 19 | 2 | 12 | Mean survival 40.5 months |
Gordon et al. 2014 [16] | 47 | Mean 55.3 | M: 24 F: 23 | 1: 2 2: 5 3: 35 NR: 5 | < 10: 16 > 10: 31 | Above: 17 Below: 24 | Radical: 43 Palliative: 1 No surgery: 3 | NR | 6 | 32 | NR |
Worhunsky et al. 2015 [3] | 48 | Median Limbs: 60 Trunk: 55 | Limbs M: 18 F: 8 Trunk M: 7 F: 15 | 1/2: 29 3: 19 | ≤ 5: 29 > 5: 19 | Above: 14 Below: 34 | Intralesional/marginal: 8 Wide: 40 | NR | 6 | 12 | NR |
Shoushtari et al. 2016g [17] | 215 | Mean 56.4 | M: 80 F: 135 | 1: 7 2: 5 3: 176 NR: 27 | < 5: 34 ≥ 5: 161 | Above: 5 Deep: 196 NR: 14 | Intralesional/marginal: 48 Wide: 95 No surgery: 47 NR: 25 | NR | NR | 113 | NR |